-
The STAR Market Records 73 Newly Disclosed M&A Transactions This Year, with Multiple Deals Accelerating Execution
Recently, M&A activity on the STAR Market has seen a new "small peak" in disclosures. Since August, 15 new transactions have been disclosed, with the total disclosed transaction value exceeding RMB 2.4 billion... -
Launching New Products, Expanding Markets: 18 STAR Market AI Companies Explore New Industry Opportunities
On September 9, 18 STAR Market AI companies—including Bohui Science & Technology, Leader Harmonious, and Arcvideo Technology—gathered at their performance briefing to disclose semi-annual performance and business strategies... -
Domestic ETF Market Reaches RMB 4.77 Trillion as Leading Fund Companies Continue to Deepen the SSE’s “Three Investment” Concept
The ETF market is ushering in unprecedented growth opportunities in 2025. According to Wind data, as of August 18, the total size of domestic ETFs has risen to RMB 4.77 trillion... -
First IPO Application Accepted under the Reinstated Fifth Set of STAR Market Listing Standards
On July 31, the Shanghai Stock Exchange accepted the STAR Market IPO application of Zhuhai Trinomab Biopharmaceutical Co., Ltd, making it the first company to be successfully accepted under the reinstated fifth set of STAR Market listing standards... -
STAR Market Companies Showcase at World Artificial Intelligence Conference, Unleashing New Momentum for Intelligent Manufacturing in China
From July 26 to 28, the World Artificial Intelligence Conference 2025 (WAIC 2025), themed "Global Solidarity in the AI Era", along with the High-level Meeting on Global AI Governance, was held in Shanghai... -
Potential Deal Exceeds $10 Billion: Hengrui Pharmaceuticals Secures Major Overseas Licensing Agreement
On July 28, Hengrui Pharmaceuticals announced that it has reached an agreement with GlaxoSmithKline Intellectual Property (No.3) Limited and GlaxoSmithKline Intellectual Property (No.4) Limited to out-license the global exclusive rights (excluding China) to its HRS-9821 program... -
China's First Publicly Offered REIT for a Headquarters-Based Sci-Tech Industrial Park Listed on SSE
On July 25, the TruValue Sunlon Industrial Park Closed-end Infrastructure REIT, managed by First Capital and its controlled subsidiary TruValue Asset Management, was officially listed on Shanghai Stock Exchange... -
Fruitful Results of Four-Year Hard Work: China's REIT Market Value Totals Over 200 Billion Yuan, with SSE Establishing a Main Platform for REIT Market Development
Since the listing of the first batch publicly traded REITs in 2021, China's REIT market has flourished for four years. As of June 2025, the total issuance scale has exceeded 180 billion yuan and the total market value has exceeded 200 billion yuan... -
Restart of IPO Review under the SSE STAR Market's Fifth Set of Standards, with Healthgen Biotechnology to Be Reviewed by the Listing Review Committee
Wuhan Healthgen Biotechnology Corp., which has been waiting for two and a half years, will be reviewed by the Listing Review Committee. This is the first enterprise applying for listing with the fifth set of SSE STAR Market standards to be reviewed... -
Offering of the First Clean Energy Holding-type Real Estate ABS and SSE's Establishment of a Multi-level REIT Market for Promoting Green Finance
On June 17, the "Taikang Asset Management-Caitong-Yuanjing New Energy Holding-type Real Estate Asset Support Special Program (Carbon Neutrality)" (Yuanjing Energy ABS) was successfully issued and established on SSE... -
SSE Series Indexes Perform Outstandingly, Helping to Build a Market Ecosystem of "Long-term Funds for Long-term Investment"
Since 2025, index-based investment has once again embraced rapid development. In particular, SSE series indexes have performed well. As of the end of May, the total scale of all products for SSE series indexes had exceeded 600 billion yuan... -
First Anniversary of the "Eight Measures": Over 30 Reforms Drive New Quality Productive Forces in the SSE STAR Market
On June 19, 2024, the China Securities Regulatory Commission issued the Eight Measures on Deepening the SSE STAR Market Reform and Supporting Scientific and Technological Innovation and the Development of New Quality Productive Forces... -
Nearly 60 Scientific Research Results of Innovative Pharmaceutical Companies on the STAR Market Attract Global Attention
From June 12 to 15, the European Hematology Association (EHA) Annual Meeting 2025 was held in Milan, Italy. This is one of the most influential academic events in the global field of hematology... -
The STAR Market Eight Measures Stimulates Index-based Investing and Channels Financial Resources Towards Technology Sector
Over the past year since its release, the STAR Market Eight Measures has facilitated improvement in capital market investment toolkit and provided policy basis for expanding STAR Market ETF products... -
140,000 Employees of Companies Listed on the SSE STAR Market Received Equity Incentives as R&D Investment Soared 10.7% over Three Years
The SSE STAR Market has always been the first choice for companies to go public with its higher IPO valuations. Hard tech companies with sci-tech innovation attributes...